Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80067721
Market status:
Marketed
Licence Status:
Active
Brand name(s):
DMSO Spray ;
DMSO Liniment ;
DMSO Pain Spray ;
MyPain Ease ;
MyPain Formula ;
MyPain Killer ;
MyPain Lini-Mint ;
MyPain LiniMint ;
MyPain Liniment ;
MyPain Linimint ;
MyPain Relief ;
MyPain Remedy ;
MyPain Rx ;
MyPain Treatment
Licence holder:
MySpray Therapeutics Inc.
Dosage Form:
Liquid
Recommended route of administration:

Topical

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults 2.0 5.0 millilitre 2 daily
Recommended use or purpose:
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis. Peppermint essential oil is used in aromatherapy to help relieve joint/muscle pain associated with strain/sprain/rheumatoid arthritis.
Risk Information:
Cautions and Warnings 
Keep out of reach of children. If accidental ingestion occurs, call a Poison Control Center Immediately. If you have severe liver or kidney disease, consult a health care practitioner prior to use. If you are taking anticoagulant medications, consult a health care practitioner prior to use. Application of this product may result in garlic-like odour on breath. If you have anemia, epilepsy or asthma, consult a health care practitioner prior to use.
Contra-Indications 
If you have broken, irritated, or sensitive skin, do not use this product. If you are pregnant or breastfeeding, do not use this product. Avoid exposure of applied areas to the sun.
Known Adverse Reactions 
Hypersensitivity, rashes, skin irritation and/or burning discomfort have been known to occur; in which case, discontinue use. If irritation persists, consult a health care practitioner. If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Mentha x piperita 5.0 %
Methyl sulfoxide 80.0 %
List of non-medicinal ingredients:
  • Glycerin
  • Magnesium chloride
Date of licensing:
2016-03-15
Revised date of licence:
2023-06-13

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: